US equities
|
MU
$1,086.47
▲+3.91%
NVDA
$236.94
▼-0.96%
SNDK
$1,699.20
▲+2.33%
SPCX
$167.37
▼-2.65%
AMD
$646.03
▼-0.52%
TSLA
$377.21
▼-0.91%
INTC
$113.50
▲+0.89%
AAPL
$335.79
▲+0.65%
MU
$1,086.47
▲+3.91%
NVDA
$236.94
▼-0.96%
SNDK
$1,699.20
▲+2.33%
SPCX
$167.37
▼-2.65%
AMD
$646.03
▼-0.52%
TSLA
$377.21
▼-0.91%
INTC
$113.50
▲+0.89%
AAPL
$335.79
▲+0.65%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
ABVC BioPharma, Inc. - Common Stock
(NQ:
ABVC
)
0.9990
+0.0290 (+2.99%)
Delayed Quote
Updated: 3:31 PM EDT, Oct 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ABVC BioPharma, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
ABVC BioPharma Provides Vitargus Update
June 30, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Stocks That Hit 52-Week Lows On Friday
↗
June 24, 2022
On Friday, 61 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 22, 2022
Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.3% to $1.03 during Wednesday's after-market session. The company's market cap stands at $33.2 million.
Via
Benzinga
ABVC BioPharma Expands Co-Development Partnership With Rgene Corporation
June 21, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Submitted Vitargus Phase II Study Plan to Australia HREC
June 16, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 13, 2022
Gainers
Via
Benzinga
93 Biggest Movers From Yesterday
↗
June 14, 2022
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 13, 2022
Via
Benzinga
70 Stocks Moving In Monday's Mid-Day Session
↗
June 13, 2022
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 13, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
June 13, 2022
Good morning, traders! We're starting off the week with a dive into the biggest pre-market stock movers for Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 10, 2022
Gainers bluebird bio (NASDAQ:BLUE) shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day...
Via
Benzinga
ABVC BioPharma Announces Termination of Two Contracts
June 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
91 Biggest Movers From Friday
↗
June 13, 2022
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Via
Benzinga
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
June 01, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Engaged by Orion BioTech to Identify Global Licensing Partners
May 25, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Prestigious Researchers to Provide Consulting Services in Connection with ABVC BioPharma's Depression Medicines
May 23, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
May 16, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Engages the FreeMind Group to Support Grant Funding
May 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
90 Biggest Movers From Yesterday
↗
May 13, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...
Via
Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
↗
May 12, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Via
Benzinga
ABVC BioPharma, Inc. Announces $4.22 Million Registered Direct Offering
May 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma ADHD Phase II Part 2 Clinical Study First Subject Treated
May 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Announces Streamlined Vitargus(R) Manufacturing Process
May 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Enters Into $3.0 Million Clinical Services Contract with NeuCen BioMed
May 03, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Completes Site Initiation Visits and Begins Enrollments for ADHD Phase II Part 2 Clinical Study
April 28, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Announces Vitargus Phase II Clinical Study Investigator Meeting
April 26, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC Biopharma Announces Fiscal Year 2021 Financial and Operational Results
March 31, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma to Present at the Maxim Group 2022 Virtual Growth Conference
March 23, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
